Atika Capital Management LLC Procept Bio Robotics Corp Transaction History

Atika Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$30.02 - $38.81 $4.35 Million - $5.63 Million	-145,000 Reduced 71.78%	57,000 $1.87 Million
Q2 2023 Aug 11, 2023	SELL	$26.7 - $37.02 $1.14 Million - $1.58 Million	-42,726 Reduced 17.46%	202,000 $7.14 Million
Q1 2023 May 12, 2023	BUY	$26.64 - $39.74 $1.2 Million - $1.79 Million	45,036 Added 22.55%	244,726 $6.95 Million
Q4 2022 Feb 13, 2023	BUY	$38.78 - $46.78 $3.05 Million - $3.68 Million	78,765 Added 65.14%	199,690 $8.3 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $1.94 Million - $3.18 Million	62,787 Added 108.0%	120,925 $5.01 Million
Q1 2022 May 13, 2022	BUY	$16.89 - $35.74 $981,950 - $2.08 Million	58,138 New	58,138 $2.03 Million

266

38M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.62B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.